Literature DB >> 15037934

Prevalence of cytomegalovirus infection in inflammatory bowel disease patients.

Yoshihisa Takahashi1, Tsuyoshi Tange.   

Abstract

PURPOSE: Although there has been an increasing number of case reports on inflammatory bowel disease complicated by cytomegalovirus infection, few reports have described its prevalence. The aim of this study was to investigate the prevalence of cytomegalovirus infection in inflammatory bowel disease and clarify the clinicopathologic features of the cases.
METHODS: We studied 55 biopsy specimens and 39 surgical specimens taken from patients clinically diagnosed as having ulcerative colitis, and 49 biopsy specimens and 30 surgical specimens from patients clinically diagnosed as having Crohn's disease. In all cases cytomegalovirus infection was histopathologically examined by means of hematoxylin and eosin and immunohistochemical staining to detect inclusion bodies in specimens.
RESULTS: Cytomegalovirus infection was confirmed in 1 of 55 biopsy specimens and in 8 of 39 surgical specimens obtained from the cases with ulcerative colitis. No cytomegalovirus inclusion bodies were exhibited in the 49 biopsy specimens and 30 surgical specimens taken from patients with Crohn's disease.
CONCLUSIONS: Cytomegalovirus infection was detected rather frequently (21 percent) in the surgical specimens of ulcerative colitis, and all cases were steroid resistant. The possibility of cytomegalovirus infection should always be taken into account in patients with ulcerative colitis who are resistant to steroid therapy.

Entities:  

Mesh:

Year:  2004        PMID: 15037934     DOI: 10.1007/s10350-003-0117-3

Source DB:  PubMed          Journal:  Dis Colon Rectum        ISSN: 0012-3706            Impact factor:   4.585


  17 in total

1.  Cytomegalovirus in inflammatory bowel disease: A systematic review.

Authors:  Tessa E H Römkens; Geert J Bulte; Loes H C Nissen; Joost P H Drenth
Journal:  World J Gastroenterol       Date:  2016-01-21       Impact factor: 5.742

2.  Cytomegalovirus infection in patients with ulcerative colitis diagnosed by quantitative real-time PCR analysis.

Authors:  Tadayuki Kou; Hiroshi Nakase; Hiroyuki Tamaki; Toyoichiro Kudo; Akiyoshi Nishio; Tsutomu Chiba
Journal:  Dig Dis Sci       Date:  2006-06       Impact factor: 3.199

3.  Cytomegalovirus infection in severe ulcerative colitis patients undergoing continuous intravenous cyclosporine treatment in Japan.

Authors:  Masaaki Minami; Michio Ohta; Teruko Ohkura; Takafumi Ando; Naoki Ohmiya; Yasumasa Niwa; Hidemi Goto
Journal:  World J Gastroenterol       Date:  2007-02-07       Impact factor: 5.742

4.  Specific endoscopic features of ulcerative colitis complicated by cytomegalovirus infection.

Authors:  Hideyuki Suzuki; Jun Kato; Motoaki Kuriyama; Sakiko Hiraoka; Kenji Kuwaki; Kazuhide Yamamoto
Journal:  World J Gastroenterol       Date:  2010-03-14       Impact factor: 5.742

5.  Cytomegalovirus Reactivation in Ulcerative Colitis Patients.

Authors:  Minh Nguyen; Kara Bradford; Xiaolan Zhang; David Q Shih
Journal:  Ulcers       Date:  2011-01-01

Review 6.  Cytomegalovirus and inflammatory bowel disease: is there a link?

Authors:  Valeria Criscuoli; Maria-Rosa Rizzuto; Mario Cottone
Journal:  World J Gastroenterol       Date:  2006-08-14       Impact factor: 5.742

7.  Clinical significance of cytomegalovirus infection in patients with inflammatory bowel disease.

Authors:  Elena Garrido; Elisa Carrera; Rebeca Manzano; Antonio Lopez-Sanroman
Journal:  World J Gastroenterol       Date:  2013-01-07       Impact factor: 5.742

8.  Viral and fungal infectious colitides.

Authors:  Matthew R Dixon
Journal:  Clin Colon Rectal Surg       Date:  2007-02

9.  Acute cytomegalovirus infection is a risk factor in refractory and complicated inflammatory bowel disease.

Authors:  Maha M Maher; Mahmoud I Nassar
Journal:  Dig Dis Sci       Date:  2008-12-18       Impact factor: 3.199

10.  Clinicopathologic characteristics of clinically relevant cytomegalovirus infection in inflammatory bowel disease.

Authors:  Akifumi Kuwabara; Haruhiko Okamoto; Takeyasu Suda; Yoichi Ajioka; Katsuyoshi Hatakeyama
Journal:  J Gastroenterol       Date:  2007-10-15       Impact factor: 7.527

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.